Skip to main content
An official website of the United States government

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Mela
mela.asefa@nih.gov
240-276-6422
5E328 Program Support Assistant | Breast and Gynecologic Cancer
Program Support Assistant | Prostate and Urologic Cancer
House, Margaret, RN, B.S.N.
margaret.house@nih.gov
240-276-7047
5E306 Deputy Chief | Prostate and Urologic Cancer
Parnes, Howard L., M.D.
howard.parnes@nih.gov
240-276-7045
5E302 Chief | Prostate and Urologic Cancer

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Debes, Jose Daniel

University Of Minnesota
United States

Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics 1R37CA297814-01 Sidney Fu, M.D.
Delaney, Joe R

Medical University Of South Carolina
United States

Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma 1R21CA292343-01A1 Goli Samimi, Ph.D., M.P.H.
Demb, Joshua Brian

University Of California, San Diego
United States

Optimal early colorectal cancer screening initiation 4R00CA267181-03 Claire Zhu, Ph.D.
Demehri, Shadmehr

Massachusetts General Hospital
United States

Immunosurveillance of breast glands with oncogenic germline mutations 5UG3CA290300-02 Altaf Mohammed, Ph.D.
Deng, Youping

University Of Hawaii At Manoa
United States

Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms 5R01CA230514-05 Christos Patriotis, Ph.D., M.Sc.
Deng, Jie

University Of Pennsylvania
United States

Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema 1R01CA289307-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Deng, Gary E

University Of California-Irvine
United States

Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial 7R21CA286330-03 Goli Samimi, Ph.D., M.P.H.
Dhakal, Soma

Virginia Commonwealth University
United States

Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers 5R61CA278445-03 Christos Patriotis, Ph.D., M.Sc.
Diaz, Juan Sebastian Gomez

University Of California At Davis
United States

A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids 3R01CA273253-03S1 Nicholas Hodges, Ph.D.
Dickinson, Sally E

University Of Arizona
United States

Investigating novel targets for topical immunoprevention of keratinocytic skin cancer 1UG3CA290443-01A1 Altaf Mohammed, Ph.D.
Digirolamo, Gregory James

Univ Of Massachusetts Med Sch Worcester
United States

Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning 5R01CA269903-04
Doescher, Mark P

University Of Oklahoma Hlth Sciences Ctr
United States

Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub 3UG1CA287044-02S1 Elyse LeeVan, M.D., M.P.H.
Doolittle, Gary C.

University Of Kansas Medical Center
United States

The University of Kansas Cancer Center's- MCA Rural NCORP- extension 3UG1CA239767-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Drake, Richard R.

Medical University Of South Carolina
United States

Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids 5R33CA267226-03
Drescher, Charles

Swedish Medical Center, First Hill
United States

The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site 3UG1CA189953-11S1 Vanessa A. White, M.P.H.